Sec. 205. The Department, taking into consideration the recommendations of its Prescription Monitoring Program Advisory Committee, may issue a rule scheduling a substance.

75 words·~1 min read·/il/chapter-720/act-570/205

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Sec. 205. The Department, taking into consideration the recommendations of its Prescription Monitoring Program Advisory Committee, may issue a rule scheduling a substance in Schedule II if it finds that:

(1)the substance has high potential for misuse;

(2)the substance has currently accepted medical use in treatment in the United States,

or currently accepted medical use with severe restrictions; and

(3)the misuse of the substance may lead to severe psychological or physiological

dependence.